Cannabinoid CB(1) receptor-interacting proteins: novel targets for central nervous system drug discovery?

por Smith, Tricia H, Sim-Selley, Laura J, Selley, Dana E
Publicado 2010

ΔFosB induction correlates inversely with CB(1) receptor desensitization in a brain region- dependent manner following repeated Δ(9)-THC administration

por Lazenka, Matthew F., Selley, Dana E., Sim-Selley, Laura J.
Publicado 2013

Sphingosine Lysolipids in the CNS: Endogenous Cannabinoid Antagonists or a Parallel Pain Modulatory System?

por Selley, Dana E., Welch, Sandra P., Sim-Selley, Laura J.
Publicado 2013

Effects of sodium on agonist efficacy for G-protein activation in μ-opioid receptor-transfected CHO cells and rat thalamus

por Selley, Dana E, Cao, Cheng-Chun, Liu, Qixu, Childers, Steven R
Publicado 2000

In vitro and in vivo functional profile characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3-carboxamido)morphinan (NAQ) as a low efficacy mu opio...

por Obeng, Samuel, Yuan, Yunyun, Jali, Abdulmajeed, Selley, Dana E., Zhang, Yan
Publicado en Eur J Pharmacol (2018)

Amphetamine maintenance differentially modulates effects of cocaine, methylenedioxypyrovalerone (MDPV), and methamphetamine on intracranial self-stimulation and nucleus accumbens d...

por Johnson, Amy R., Banks, Matthew L., Selley, Dana E., Negus, S. Stevens
Publicado en Neuropsychopharmacology (2018)

Opioid receptor selectivity profile change via isosterism for 14-O-substitued naltrexone derivatives

por Zhang, Yan, Elbegdorj, Orgil, Yuan, Yunyun, Beletskaya, Irina O., Selley, Dana E.
Publicado 2013

Structure activity relationship studies of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3′-carboxamido)morphinan (NAQ) analogues as potent opioid receptor ligan...

por Yuan, Yunyun, Elbegdorj, Orgil, Beletskaya, Irina O., Selley, Dana E., Zhang, Yan
Publicado 2013

Effects of the Novel, Selective and Low-Efficacy Mu Opioid Receptor Ligand NAQ on Intracranial Self-Stimulation in Rats

por Altarifi, Ahmad A., Yuan, Yunyun, Zhang, Yan, Selley, Dana E., Negus, S. Stevens
Publicado en Psychopharmacology (Berl) (2014)

Low dose combination of morphine and Δ(9)-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors

por Smith, Paul A., Selley, Dana E., Sim-Selley, Laura J., Welch, Sandra P.
Publicado 2007

14-O-Heterocyclic-substituted naltrexone derivatives as non-peptide mu opioid receptor selective antagonists: Design, synthesis, and biological studies

por Li, Guo, Aschenbach, Lindsey C. K., He, Hengjun, Selley, Dana E., Zhang, Yan
Publicado 2008

Predicting the CRIP1a-cannabinoid 1 receptor interactions with integrated molecular modeling approaches

por Ahmed, Mostafa H., Kellogg, Glen E., Selley, Dana E., Safo, Martin, Zhang, Yan
Publicado en Bioorg Med Chem Lett (2014)

3-Substituted Pyrazole Analogs of the Cannabinoid Type 1 (CB(1)) Receptor Antagonist Rimonabant: Cannabinoid Agonist-Like Effects in Mice via Non-CB(1), Non-CB(2) Mechanism

por Wiley, Jenny L., Selley, Dana E., Wang, Pinglang, Kottani, Rudresha, Gadthula, Srinivas, Mahadeven, Anu
Publicado 2012

Cannabinoid Receptor Interacting Protein (CRIP1a) attenuates CB(1)R signaling in neuronal cells

por Blume, Lawrence C., Eldeeb, Khalil, Bass, Caroline E., Selley, Dana E., Howlett, Allyn C.
Publicado en Cell Signal (2014)

Δ(9)-Tetrahydrocannabinol Experience Influences ΔFosB and Downstream Gene Expression in Prefrontal Cortex

por Lazenka, Matthew F., Kang, Minho, De, Dipanjana Datta, Selley, Dana E., Sim-Selley, Laura J.
Publicado en Cannabis Cannabinoid Res (2017)

Exploring naltrexamine derivatives featuring azaindole moiety via nitrogen-walk approach to investigate their in vitro pharmacological profiles at the mu opioid receptor

por Ma, Hongguang, Wang, Huiqun, Gillespie, James C., Mendez, Rolando E., Selley, Dana E., Zhang, Yan
Publicado en Bioorg Med Chem Lett (2021)

Regional enhancement of cannabinoid CB(1) receptor desensitization in female adolescent rats following repeated Δ(9)-tetrahydrocannabinol exposure

por Burston, James J, Wiley, Jenny L, Craig, Abimbola A, Selley, Dana E, Sim-Selley, Laura J
Publicado 2010

Chronic Neuropathic Pain in Mice Reduces μ-Opioid Receptor-Mediated G-protein Activity in the Thalamus

por Hoot, Michelle R., Sim-Selley, Laura J., Selley, Dana E., Scoggins, Krista L., Dewey, William L.
Publicado 2011

Early adolescent nicotine exposure affects later-life hippocampal mu-opioid receptors activity and morphine reward but not physical dependence in male mice

por Kota, Dena, Alajaji, Mai, Bagdas, Deniz, Selley, Dana E., Sim-Selley, Laura J., Damaj, M. Imad
Publicado en Pharmacol Biochem Behav (2018)

Chronic Heroin Self-Administration Desensitizes μ Opioid Receptor-Activated G-Proteins in Specific Regions of Rat Brain

por Sim-Selley, Laura J., Selley, Dana E., Vogt, Leslie J., Childers, Steven R., Martin, Thomas J.
Publicado en J Neurosci (2000)